Stay updated on Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe history now records a new revision, v3.6.3, as the current entry, replacing the previous v3.6.2, indicating the page has been updated to a newer release.SummaryDifference0.1%

- Check24 days agoChange DetectedA new revision entry v3.6.2 was added to the history and the v3.6.0 entry was removed, indicating a small metadata update to the page's version history.SummaryDifference0.1%

- Check38 days agoChange DetectedThe study history now shows that recruitment has ended. It also adds the new revision tag v3.6.0 and removes the previous v3.5.5 entry from the history.SummaryDifference0.4%

- Check45 days agoChange DetectedA new revision entry v3.5.5 was added to the revision history. The prior v3.5.4 entry was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision entry, Revision: v3.5.4, was added to the page's history, replacing the previous v3.5.3 entry.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page’s version footer was updated from revision v3.5.2 to v3.5.3, reflecting a backend/UI software update for the ClinicalTrials.gov site rather than a change to the trial record itself.SummaryDifference0.1%

Stay in the know with updates to Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cobimetinib Combo vs. Pembrolizumab in Melanoma Clinical Trial page.